Douglas Mann

Professor of Medicine

Washington University in Saint Louis School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Douglas Mann is a Professor of Medicine at Washington University in St. Louis School of Medicine, USA. His recent research focuses on the direction of cardiology journals in the context of global change, as well as improving the safety and efficacy of phase II clinical trials in heart failure. His extensive publications contribute significantly to the field of cardiology and clinical trial methodology.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (7)

Marie-Joe Dib

Imperial College London

UNITED KINGDOM

View details

Sean Pinney

University of Chicago

UNITED STATES

View details

Daphne Watkins

Professor

University of Michigan

UNITED STATES

View details

Joel Schilling

Washington University School of Medicine

UNITED STATES

View details

Mark Richards

Professor

National University of Singapore (NUS)

SINGAPORE

View details

Christopher B Granger

Duke University Medical Center

UNITED STATES

View details

Payman Zamani

Assistant Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Douglas Mann

Research Interests

Explore related searches

Contact this professor

About

Articles (26)

Articulating the JACC Journals’ Direction in Times of Global Change

Derisking Phase II Clinical Trials in Heart Failure

Articulating the JACC Journals’ Direction in Times of Global Change

Articulating the JACC Journals’ Direction in Times of Global Change

Articulating the JACC Journals’ Direction in Times of Global Change

Articulating the JACC Journals’ Direction in Times of Global Change

Articulating the JACC Journals’ Direction in Times of Global Change

Articulating the JACC Journals’ Direction in Times of Global Change

Articulating the JACC Journals’ Direction in Times of Global Change

Articulating the JACC Journals’ Direction in Times of Global Change

Prognostic Significance and Biologic Associations of Senescence‐Associated Secretory Phenotype Biomarkers in Heart Failure

The Pathobiology of Myocardial Recovery and Remission: From Animal Models to Clinical Observations in Heart Failure Patients

Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial

The Emerging Field of Cardioimmunology: Past, Present and Foreseeable Future

Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI

Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study

Distinct Inflammatory Milieu in Patients With Right Heart Failure

Detecting and Targeting Inflammation in Genetic Cardiomyopathies

Recurrent Myocardial Injury Leads to Disease Tolerance in a Murine Model of Stress-Induced Cardiomyopathy

Reply to Madias

Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial

Refining the reproducibility of a murine model of stress-induced reversible cardiomyopathy

Artificial Intelligence Discusses the Role of Artificial Intelligence in Translational Medicine

Recurrent Adrenergic Stress Provokes Persistent Myocarditis in PD-1–Deficient Mice

The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial

Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure

Collaborators (7)

Marie-Joe Dib

Sean Pinney

Daphne Watkins

Joel Schilling

Mark Richards

Christopher B Granger

Payman Zamani

Make your next move.